The Fly | ZBH

Today

Zimmer Biomet price target lowered by $10 at Evercore ISI, here's why

8:49 AM

Tuesday

Pacira Zimmer to divest iovera degrees to Biomet for $70M upfront

Jun 30, 7:40 AM

Over a week ago

Zimmer Biomet price target lowered by $2 at Citi, here's why

May 28, 6:59 AM

Zimmer Biomet increases share repurchase program by $250M

May 12, 6:35 AM

Zimmer Biomet participates in a conference call with JPMorgan

Apr 29, 11:18 AM

Zimmer Biomet price target lowered by $6 at Truist, here's why

Apr 29, 9:52 AM

Zimmer Biomet price target lowered by $5 at JPMorgan

Apr 29, 8:43 AM

Zimmer Biomet price target lowered by $10 at Canaccord, here's why

Apr 29, 7:31 AM

Zimmer Biomet price target lowered by $5 at Stifel

Apr 29, 7:21 AM

Zimmer Biomet price target lowered by $8 at Baird, here's why

Apr 29, 7:00 AM

Zimmer Biomet price target lowered by $3 at Citi

Apr 29, 6:38 AM

Zimmer Biomet price target lowered by $15 at Citizens, here's why

Apr 29, 5:55 AM

Zimmer Biomet price target lowered by $6 at Barclays, here's why

Apr 29, 5:45 AM

Morning Movers: Coca-Cola and Centene higher after earnings

Apr 28, 8:54 AM

Zimmer Biomet raises FY26 adjusted EPS view to $8.40-$8.55 from $8.30-$8.45

Apr 28, 6:40 AM

Zimmer Biomet reports Q1 EPS $2.09, consensus $1.86

Apr 28, 6:38 AM

Zimmer Biomet CFO Suketu Upadhyay to depart

Apr 28, 6:30 AM

Notable companies reporting before tomorrow's open

+10

Apr 27, 2:27 PM

Nike downgraded, Starbucks upgraded: Wall Street's top analyst calls

+12

Apr 13, 9:58 AM

Zimmer Biomet initiated with neutral view at Leerink, here's why

Apr 13, 7:34 AM

William Blair med tech analyst holds an analyst/industry conference call

Apr 10, 12:57 PM

Extensive Product Portfolio: Zimmer Biomet offers a comprehensive suite of orthopedic products, including reconstructive products (hips and knees), spine and CMF (craniomaxillofacial) products, trauma, dental, and surgical technologies, catering to a wide range of surgical needs and patient demographics.

Global Market Presence: With operations and sales in numerous countries worldwide, ZBH benefits from a broad geographic reach, enabling it to penetrate diverse markets and leverage global healthcare spending trends.

Strong Brand Reputation and Surgeon Trust: The company has built a long-standing reputation for quality and innovation, fostering deep relationships and trust among orthopedic surgeons who rely on their devices for patient outcomes.

Regulatory Compliance Risks: Zimmer Biomet operates in a highly regulated industry globally, and failure to comply with existing or new regulations, or delays in product approvals, could significantly impact its operations and sales.

Product Liability and Litigation Risks: Given the nature of its implantable medical devices, Zimmer Biomet faces inherent risks of product liability claims, lawsuits, and recalls, which can result in substantial financial costs and reputational damage.

Competitive Market and Pricing Pressures: The orthopedic and medical device markets are highly competitive, with constant pressure from rivals, technological advancements, and demands from healthcare providers for lower prices, which can erode market share and profitability.